Nottingham University Hospitals NHS Trust was awash with red as staff showed their support for research by wearing something red as part of the celebrations for International Clinical Trials Day on Monday 20th May 2013.
NUH R&I seeks to appoint a QA/GCP Manager to assure the quality of clinical research undertaken within Nottingham University Hospitals NHS Trust in accordance with legislative and best practice requirements. This is a key role in the co-ordination of working practices, policy implementation and preparation for external audits and MHRA inspection. Continue reading
To tackle uncertainty about dosing schedule for bevacizumab (Avastin), we are conducting a multicentre randomised trial in England. This study, the TANDEM trial, is a factorial trial comparing low dose with standard dose bevacizumab, and monthly with two monthly review schedules. This issue is of such importance to the NHS, that the unusual step has been taken for a consortium of PCT commissioners in the East Midlands (the East Midlands Specialised Commissioning Group) to commission this trial. Continue reading
The 9 million people in the UK with significant hearing loss have a greater hope of improving their condition with the announcement of a major NIHR award for a Nottingham Hearing & Deafness Biomedical Research Unit. The unit, based at … Continue reading
NUH Research and Innovation Team Member Short Biographies
Dr Brian Thomson
Director of Research
Dr Brian Thomson qualified in Medicine from the University of Edinburgh and trained in medicine in Edinburgh, London and Cambridge before being appointed an Associate Professor and Honorary Consultant … Continue reading
The Nursing and Midwifery Research Strategy Group’s “Engage, Enthuse, Empower” conference celebrates the diversity of research and innovation undertaken by non-medical professionals within Nottingham University Hospitals NHS Trust. It’s taking place on Tuesday 19th April 2011, 08.30 – 16.00 at … Continue reading
Individual Researchers/Investigators engaged in research at NUH are not authorised to sign any research contract on behalf of NUH. All research contracts should be brought to the attention of the R&D Department who will action accordingly. The authorised … Continue reading
Commercial research is important to NUH as the driving force for the adoption and diffusion of innovation.
It is through this process that new treatments, devices or laboratory tests are studied and brought forward for use by patients and staff.
Nottingham … Continue reading